256 related articles for article (PubMed ID: 10383911)
21. Spontaneous and ethylnitrosourea-induced mutation fixation and molecular spectra at the lacI transgene in the Big Blue rat-2 embryo cell line.
Zimmer DM; Zhang XB; Harbach PR; Mayo JK; Aaron CS
Environ Mol Mutagen; 1996; 28(4):325-33. PubMed ID: 8991060
[TBL] [Abstract][Full Text] [Related]
22. Tissue-specific mutant frequencies and mutational spectra in cyclophosphamide-treated lacI transgenic mice.
Gorelick NJ; Andrews JL; deBoer JG; Young R; Gibson DP; Walker VE
Environ Mol Mutagen; 1999; 34(2-3):154-66. PubMed ID: 10529740
[TBL] [Abstract][Full Text] [Related]
23. Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure.
Sisk SC; Pluta LJ; Meyer KG; Wong BC; Recio L
Mutat Res; 1997 Jul; 391(3):153-64. PubMed ID: 9268040
[TBL] [Abstract][Full Text] [Related]
24. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP
Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
[TBL] [Abstract][Full Text] [Related]
25. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
[TBL] [Abstract][Full Text] [Related]
26. Detection of tamoxifen-DNA adducts on lacI genes using DNA polymerase stop assay.
Cheng RH; Gant TW
Changgeng Yi Xue Za Zhi; 1999 Jun; 22(2):189-96. PubMed ID: 10493022
[TBL] [Abstract][Full Text] [Related]
27. Mutation frequency in the lacI gene of liver DNA from lambda/lacI transgenic mice following the interaction of PCBs with iron causing hepatic cancer and porphyria.
Davies R; Clothier B; Smith AG
Mutagenesis; 2000 Sep; 15(5):379-83. PubMed ID: 10970442
[TBL] [Abstract][Full Text] [Related]
28. Spontaneous mutations in lacI-containing lambda lysogens derived from transgenic mice: the observed patterns differ in liver and spleen.
Knöll A; Jacobson DP; Kretz PL; Lundberg KS; Short JM; Sommer SS
Mutat Res; 1994 Nov; 311(1):57-67. PubMed ID: 7526175
[TBL] [Abstract][Full Text] [Related]
29. The in vivo mutagenicity and mutational spectrum at the lacI transgene recovered from the spleens of B6C3F1 lacI transgenic mice following a 4-week inhalation exposure to 1,3-butadiene.
Recio L; Pluta LJ; Meyer KG
Mutat Res; 1998 Jun; 401(1-2):99-110. PubMed ID: 9639685
[TBL] [Abstract][Full Text] [Related]
30. Oxazepam is mutagenic in vivo in Big Blue transgenic mice.
Shane BS; deBoer JG; Glickman BW; Cunningham ML
Carcinogenesis; 1999 Jul; 20(7):1315-21. PubMed ID: 10383906
[TBL] [Abstract][Full Text] [Related]
31. Induction of mutations by 2-acetylaminofluorene in lacI transgenic B6C3F1 mouse liver.
Ross JA; Leavitt SA
Mutagenesis; 1998 Mar; 13(2):173-9. PubMed ID: 9568591
[TBL] [Abstract][Full Text] [Related]
32. Similarities in sunlight-induced mutational spectra of CpG-methylated transgenes and the p53 gene in skin cancer point to an important role of 5-methylcytosine residues in solar UV mutagenesis.
You YH; Pfeifer GP
J Mol Biol; 2001 Jan; 305(3):389-99. PubMed ID: 11152598
[TBL] [Abstract][Full Text] [Related]
33. Mutagenicity of the potent rat hepatocarcinogen 6BT to the liver of transgenic (lacI) rats: consideration of a reduced mutation assay protocol.
Lefevre PA; Tinwell H; Ashby J
Mutagenesis; 1997 Jan; 12(1):45-7. PubMed ID: 9025097
[TBL] [Abstract][Full Text] [Related]
34. Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer.
Besaratinia A; Bates SE; Pfeifer GP
Cancer Res; 2002 Aug; 62(15):4331-8. PubMed ID: 12154037
[TBL] [Abstract][Full Text] [Related]
35. Extent of CpG methylation is not proportional to the in vivo spontaneous mutation frequency at transgenic loci in Big Blue rodents.
Monroe JJ; Manjanatha MG; Skopek TR
Mutat Res; 2001 May; 476(1-2):1-11. PubMed ID: 11336978
[TBL] [Abstract][Full Text] [Related]
36. Spontaneous mutation in lacI transgenic mice: a comparison of tissues.
de Boer JG; Provost S; Gorelick N; Tindall K; Glickman BW
Mutagenesis; 1998 Mar; 13(2):109-14. PubMed ID: 9568581
[TBL] [Abstract][Full Text] [Related]
37. A novel lacI transgenic mutation-detection system and its application to establish baseline mutation frequencies in the scid mouse.
Andrew SE; Pownall S; Fox J; Hsiao L; Hambleton J; Penney JE; Kohler SW; Jirik FR
Mutat Res; 1996 Oct; 357(1-2):57-66. PubMed ID: 8876680
[TBL] [Abstract][Full Text] [Related]
38. Spontaneous mutants recovered from liver and germ cell tissue of low copy number lacI transgenic rats.
de Boer JG; Erfle H; Holcroft J; Walsh D; Dycaico M; Provost S; Short J; Glickman BW
Mutat Res; 1996 Jun; 352(1-2):73-8. PubMed ID: 8676919
[TBL] [Abstract][Full Text] [Related]
39. Molecular analysis of lacI mutants from transgenic fibroblasts exposed to 1,2-epoxybutene.
Saranko CJ; Pluta LJ; Recio L
Carcinogenesis; 1998 Nov; 19(11):1879-87. PubMed ID: 9854997
[TBL] [Abstract][Full Text] [Related]
40. Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene.
Saranko CJ; Meyer KG; Pluta LJ; Henderson RF; Recio L
Mutat Res; 2001 Jan; 473(1):37-49. PubMed ID: 11166025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
